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Objectives: Clostridioides difficile (C. diff) is a common but challenging infection both 
financially and medically. Due to these difficulties, Clostridioides difficile infection (CDI) 
caused by C. diff is a mandatory reportable disease in Nebraska and as such has been a priority 
disease targeted by various disease control practices across many hospitals. All CDI laboratory 
results are reported electronically through the Nebraska Electronic Disease Surveillance System 
(NEDSS). However, capturing and conceptualizing the true burden of CDIs in Nebraska has not 
been adequately accomplished since monitoring of CDIs began. The objective of this study is to 
examine the trends of C. diff infections and related deaths in Nebraska from 2018-2020. In 
addition, this study seeks to create a system to track CDIs in Nebraska through Geographic 
Information System (GIS) mapping for better conceptualizing of CDI burden in the state. 
Methods: To examine the burden of C. diff on Nebraska, descriptive epidemiology using lab 
results reported in NEDSS from 2018-2020 and deaths reported with CDI association during the 
same timespan were performed using the SAS analysis tool. Social vulnerability index (SVI) 
provided by the Center for Disease Control and Prevention (CDC) was used to compare varying 
counties and CDI counts. An interactive map using GIS was created to document and visualize 
CDI prevalence of 2020 cases across the state of Nebraska.  
Results: 8,334 CDI cases were recorded during the three-year span with case counts decreasing 
36.5% from 2018-2020. The three-year prevalence rate for Nebraska was 459.07 per 100,000. 
Yearly incidence rates decreased yearly from 181.56 to 130.42 per 100,000 over the three-year 
span. 127 CDI-associated deaths were identified between 2018-2020 with increasing and 
decreasing numbers and rates yearly. Demographic information including gender, age, 
specimen/test type, race, ethnicity, and infection type of all 8,334 cases were recorded and 
reported. In addition to demographics, over 600 medical facilities and nursing homes were 
identified and stored into the state’s system for future identification of CDI case locating. 
ANOVA and logistic regression analysis indicated that residents of high-risk SVI counties were 
less likely to have a CDI than both moderate and low-risk SVI county residents. Lastly, an 
interactive GIS map was created depicting 2020 case demographics and rates as well as case 
numbers and rates by local health department (LHD) jurisdiction. 
Conclusion: The overall burden of CDIs has been decreasing in Nebraska since 2018, however 
death counts and rates have remained similar. While complications associated with CDIs due to 
possible comorbidities may be harder to predict and prevent, this study has shown the positive 
effect of antimicrobial stewardship on CDI prevalence statewide. Case demographics that have 
been recorded as well as SVI analysis by this study have created a baseline understanding of at-
risk populations in Nebraska and when combined with the GIS map can be used to locate CDI 
outbreaks and decrease response time. Furthermore, the creation of the CDI GIS map has created 
an efficient means of disease tracking and monitoring, and specifically for all common and 
reportable healthcare-associated infections (HAIs) in Nebraska as it can be used as a 
foundational template. Overall, this study was able to successfully describe the epidemiological 
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Clostridioides difficile in Healthcare 
 
 Clostridioides difficile (C. diff) is a toxin-producing bacterium often 
associated with colitis and severe diarrhea and is known to frequently reoccur after a first C. diff 
infection (CDI). CDIs are most seen in nursing home residents and are a leading health care 
associated infection in the United States.1 Studies have shown that CDIs make up 10-30% of 
healthcare infections with asymptomatic colonization of C. diff seen in 2-3% in healthy 
individuals and 10-25% of hospitalized patients.9-12 Hospitals are unique, complex environments 
that continually change with the flow of people that reside and work within them. One important 
aspect of C. diff is its ability to live on surfaces for up to five months suggesting that the hospital 
environment is an important risk multiplier and place of transmission for C. diff.3 Consideration 
that inpatients are not always static and may be granted liberalized movement permissions in 
specific instances, it is not inconceivable that a patient can acquire a C. diff infection during their 
stay.4,29 For those already infected with C. diff, viral shedding of spores can cause contamination 
of surfaces, devices, and of healthcare workers’ bodies and attire creating reservoirs for C. diff 
usually transmitted via the fecal-oral route.7,8 As such, a quarter of hospitalized patients will 
contract a hospital-acquired infection indicating that controlling pathogens such as C. diff should 
be a top priority.5,6 
Clostridioides difficile in Long-Term Facilities 
 Another area of considerable CDI prevalence are long-term care facilities 
(LTCFs). These types of facilities include assisted living facilities, skilled nursing facilities, 
nursing homes, and rehabilitation centers. Common occurrences of CDIs can be correlated to 
extended antibiotic usage, existing comorbidities, and age. Many residents of LTCFs are elderly 
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and as such, antibiotic usage is higher amongst LTCF populations than the general population. 
This in conjunction with older age and comorbidities make LTCFs a common reservoir of C. 
diff. Due to these risk factors, incidence rates of CDIs have been reported to upwards of 50% of 
residents in observed LTCFs.16-20 Also keeping into consideration that residents are living in 
these facilities, spread of C. diff through interactions among residents via group gatherings and 
events, and the lunch hall further increases the risk of transmission and CDIs. In addition, elderly 
persons are more likely prone to complications if infected with C. diff. This unique dynamic 
creates a distinctive priority to control the spread of C. diff in LTCFs. 
Clostridioides difficile in the General Population 
 CDIs have demonstrated financial and clinical burdens on a national and state 
level. One study found the average length of stay for CDI inpatient treatment has been 
determined to be around 11 days and consequently, making CDIs an expensive infection with 
average CDI-attributable costs around $42,316 per infection.2 Another study aimed specifically 
at determining the burden of CDIs in Massachusetts found rates of CDIs to be 132.5 per 100,000 
people in 2016 and a CDI mortality rate of 6.4 per 100,000 in 2014.13 Of the positive cases in the 
study, 55.6% of positives were female, and incidence rates increased with age.13 These studies 
signify an extreme burden on states around the country and warrants further investigation by the 
states individually to understand their own C. diff burden. Yet the Massachusetts study is the 
only published C. diff epidemiological study performed on a statewide level.13 Even then, this 
study is not indicative of the Nebraska population and has incidence and mortality rate 
calculations in separate years and over a one-year span. To understand Nebraska’s own unique 
C. diff situation, a descriptive study must be undertaken that includes a multi-year timespan that 
is also broken down yearly. 
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Vulnerabilities and Clostridioides difficile 
 To study the effects of vulnerabilities on disease burden and catastrophic 
events, the CDC has created a social vulnerability index (SVI) for counties in each state with the 
last update being in 2016. This index is based on 15 social factors grouped into four categories 
and is used to indicate vulnerability to a hazardous event on a 0 to 1 scale. The first category is 
socioeconomic status that includes factors such as persons who are below the poverty line, 
unemployed, have low income, or no high school diploma. The second category is household 
composition and disability made up of factors such as persons 65 and older or 17 and younger, 
persons with disabilities, and single-parent households. The third category is minority status and 
language made up of two factors: persons who are part of a minority or speak English “less than 
well”. The final category is housing and transportation made up of factors like multi-unit 
structures, mobile homes, crowding, persons with no vehicle, and group quarters. A higher score 
indicates a higher vulnerability. 
Infection Control Programs for Clostridioides difficile 
 Various infection control programs have been put into place to control HAIs 
including CDI. The most prominent practice attributable to high rates of CDI is inappropriate 
prescribing and use of antimicrobials specifically, dosage, treatment duration, decision to 
withhold or initiate antimicrobials, and regimens.22-27 This has led to microbial stewardship 
programs aimed at improving antimicrobial practices to contain the spread of pathogens such as 
C. diff. However, a systematic review has found that interventions placed on prescribing of 
antimicrobials had little impact on both adherence to guidelines and decreasing the number of 
antimicrobials being described in LTCFs.21 Hospitals have adapted to increasing C. diff 
challenges through more microbial stewardship programs that have shown success in decreasing 
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CDIs. Practices such as education of staff, reinforcing of proper handwashing and isolation 
protocols, and monthly assessment and reviews of the practices have shown to markedly 
decrease CDIs in the hospital setting.28 Such practices have been implemented statewide in 
Nebraska. While stewardship program implementors understand that there is a C. diff issue in 
Nebraska, they do not have a complete visual understanding of the true burden that CDIs have on 
the state. Nor do they have adequate conceptualization of the current C. diff situation in 
Nebraska. This lack of information does not provide appropriate feedback to these programs 
regarding their efficacy in lowering the prevalence of CDIs. This project aims to give these 
programs the tangible evidence to evaluate and adjust their protocols. 
Use of Surveillance Data for Clostridioides difficile 
 The increased sophistication and advancement of the health care field has 
allowed for better tracking and surveillance of diseases. Nebraska has a statewide reporting 
system known as the Nebraska Electronic Disease Surveillance System (NEDSS) that allows for 
labs to be electronically reported and accessible for health systems purposes. This system 
provides the data to conduct studies that would otherwise be extremely limited to perform. 
Through NEDSS, each lab performed is reported from every hospital in the state to allow 
tracking and reporting of each mandatory disease. For C. diff specifically, NEDSS has been 
recording labs performed since 2018 making NEDSS a primary source to analyze CDI data as 
well as identifying clusters and outbreaks for immediate containment. As well as surveillance to 
report disease incidences, death certificate data has become a more sophisticated means to help 
track deaths associated with specific diseases. The Nebraska Electronic Death Registration 
System (NEDRS) is one such database where these deaths and their causes are reported. Using 
NEDSS in tandem with NEDRS we can describe the burden of CDIs in Nebraska.  
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 Every state health department has an electronic reporting system for 
surveillance purposes just like the state of Nebraska. Through this surveillance data some state 
health departments have also done their own tracking and monitoring of CDIs whether by their 
own design or through the Center for Disease Control’s (CDC) Emerging Infections Program 
(EIP). Through the EIP, the CDC has launched a C. diff surveillance program involving 10 state 
health departments and several metropolitan areas residing within the same state. While this is 
good for estimation of national population-based incidence and disease burden, this is not an 
efficient means to describe Nebraska’s unique CDI burden. Furthermore, the states involved in 
the EIP create yearly state CDI reports only based on the metropolitan areas involved within the 
program. While this can paint an abstract picture of CDI burden, it does not adequately portray 
the true burden in the entire state. This project aims to take CDI surveillance to the next level 
with the use of Nebraska’s electronic reporting system (ELR) and the addition of mapping. By 
analyzing the lab data and mapping the incidences of CDIs we will be able to better understand 
disease control program efficacy, the burden of CDIs on the state, C. diff hotspots that require 
more attention for targeted control measures, and potentially point towards CDI burden 
associated with antimicrobial use/misuse within identified hotspots in Nebraska. 
Using Mapping for Clostridioides difficile 
 One way to conceptualize the spatial clustering and transmission of disease 
has come with Geographic Information System (GIS) techniques. While spatial analysis has been 
widely used since the 1960s it has developed into a prominent epidemiological tool as seen 
during the 2019 novel coronavirus pandemic.14,15 With the advancement of GIS mapping, 
technologies such as this can provide higher insights and conceptualizations of disease burden in 
epidemiological practices. GIS can be used to pinpoint clustered outbreaks, identify areas that 
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are underserved, and predict growth and transmission of disease.14 The state of Nebraska has 
created GIS mapping for the 2019 novel coronavirus pandemic statewide, but it has not used this 
type of epidemiological practice to track other diseases and has only used GIS mapping for 
listing the locations of the state’s biggest hospitals so the rural population can find the nearest to 
their area of residence. GIS has many applicable uses including creating an easy-to-read story 
map that allows the community and healthcare community to understand significant health 
burdens that are affecting both their state and local area. COVID was the first major disease that 
highlighted the applicability of GIS in epidemiology, but it is not the only major disease in the 
world.  C. diff is a significant problem and GIS should be used to create spatial mapping for 
tracking purposes of CDI incidence in Nebraska. 
Project Aim 
 This project seeks to create a baseline understanding of the current ongoing 
C. diff situation in Nebraska. Using the state’s surveillance data, this study will be able to 
calculate incidence rates, mortality rates, as well as identify the geographic areas most affected 
with CDIs for targeted interventions. The study will also create an epidemiological description of 
CDI cases by assessing exposure statuses within the affected CDI population. This will help gain 
better insight into more at risk individuals in the state. Secondly, this project aims to determine 
the efficacy of current stewardship programs. CDI laboratory results have been collected in 
Nebraska’s surveillance data since 2018, so a longitudinal study of trends on CDIs can be 
achieved. Moreover, this project aims to create a mapping system that can continuously be 
updated to monitor CDI cases. The state health department contains the software to use GIS 
mapping. By using this software, a map of the state with corresponding locations where CDI 
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incidences have occurred will create a quick and easier concept to visualize the current C. diff 
situation in Nebraska. 
Methods 
Study Design and Study Setting 
 This project is a retrospective, population-level, descriptive epidemiological 
and spatial mapping study. Between the years 2018-2020, there have been over 8,000 CDI lab 
tests performed. To perform this study, all CDI results during this timeframe were extracted from 
NEDSS, placed into one excel file, and broken down into three separate excel files by year in 
which the CDI occurred. The master Excel file was analyzed by the SAS analysis tool coded to 
perform each descriptive task. Cleaning the data consisted of removing duplicate and incomplete 
data.  
Study Population 
 To study mortality, incidence, and prevalence of CDIs in Nebraska, cases 
who have a positive laboratory test or had C. diff listed on their death certificate were the study 
population with the 2010 census tract as the denominator to calculate these rates. For incidence 
and prevalence calculations, all positive CDIs were included. For descriptive epidemiology 
purposes in this project, cases with a positive CDI lab were the study population. Another aspect 
that needed to be taken into consideration is that reoccurring episodes of CDI do occur. Per CDC 
guidelines, positive labs between 2-8 weeks in the same case are considered recurrent episodes 
and positive labs within two weeks are considered duplicate episodes. Our data cleaning 
incorporated these rules implemented by the CDC. Any consecutive positive lab that was within 
two weeks of the first positive lab was considered a duplicate and not a CDI. However, recurrent 




 We used two sources of data: NEDSS and NEDRS. NEDSS is a real-time, 
integrated electronic lab recording system used by the entire state’s healthcare system. NEDSS 
contains every laboratory test, positive or negative, for each reportable disease in Nebraska. Each 
event is recorded into the system for archiving and eventual analysis. NEDRS is similar to 
NEDSS but with death certificate data. NEDRS reports contain the main cause of death in 
addition to a secondary, and tertiary cause of death. C. diff listed in any order of cause of death 
was considered for mortality data. 
Data Extraction, Data Cleaning, and Variables 
 The ELR systems for Nebraska contain raw data of every lab that is 
performed in Nebraska. This requires specific SAS coding to be able to extract C. diff specific 
data. Using the PROC SQL command in SAS we were able to specifically target every CDI lab 
that was performed between 2018 and 2020 and extract all those labs out of the NEDSS data 
system. However, the data extracted was still raw and required significant data cleaning to 
perform any analysis and descriptive epidemiology. 
 The ELR system comes directly from the hospitals that report the 
information. The interaction between facilities that order the lab test and facilities that perform 
the lab test are dynamic. Many facilities do not have the means to perform CDI labs and need 
other facilities to perform the test for them. This creates a confusion on where the CDI has been 
identified as some reporting facilities do not explicitly list which facility requested the CDI lab. 
This in addition to different styles in reporting such as only reporting the ordering facility’s 
address create a need to perform detective-like work by backtracking where the CDI occurred. 
To do this, all ordering facilities and reporting facilities were organized, and the data cleaning 
12 
 
process consisted of going through each ordering facility’s address, identifying which facility 
that address belongs to, and unifying all ordering facilities in the SAS coding. 
 In addition, LTCFs are not included in the ELR systems. CDI has a higher 
prevalence in the LTCF areas so creating a LTCF variable to document this was pertinent. 
Typically, the LTCF is listed in the ordering facility so by using the same process as above we 
were able to pick out LTCFs that ordered a CDI lab to create the new variable. In addition, 
residents usually have the LTCF address listed as their own, using this data we were also able to 
identify several LTCFs where a CDI occurred. Another variable that required cleaning was the 
test type and specimen type. There are a substantial number of different names for a CDI test in 
the ELR system but whether they were positive or negative was consistent. Test types were 
organized and then categorized into four different categories: polymerase chain reaction 
(PCR)/nucleic acid amplification test (NAAT), enzyme immunoassay (toxin) (EIA), culture, and 
antigen. Specimen types were organized into unique but matching categories depending on the 
specimen type. The other variables that were cleaned were county where the CDI occurred and 
the local health department that has jurisdiction over which county. Once the county where the 
CDI occurred was identified the health department that provides services to that county was then 
able to be identified. 
 Variables such as specimen type, test performed, age, gender, race, infection 
type, ethnicity, and Morbidity and Mortality Weekly Report (MMWR) week were recorded from 
positive CDI labs for simple descriptive analysis. MMWR week is a 52-week timeframe 
corresponding to the 52 weeks in a calendar year developed by the CDC. Rather than reporting 
cases by the day, grouping cases within the same week allows for efficient grouping and easier 
identifying of potential clustering of cases. Infection type categorized whether the CDI was 
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classified as a community associated infection, meaning the CDI was acquired outside a medical 
facility or clinic, or a healthcare associated infection meaning that the CDI was acquired in a 
medical facility. Gender, age, race, ethnicity, infection type, and MMWR week did not require 
much to any cleaning. 
Study Analysis and Descriptive Study 
 CDI incidence and mortality rates for each year were calculated using the 
ELR surveillance data. Since this study does have a timeframe of three years, a three-year 
prevalence and crude mortality rate were calculated in addition to the yearly rates. Yearly 
incidence rates were calculated by dividing the number of positive CDI cases by the state of 
Nebraska’s population according to the 2010 census and multiplied by 100,000 as incidence rates 
are reported per 100,000 people usually. The three-year prevalence was calculated by the total 
positive CDIs over the three years and divided by Nebraska’s population. Mortality rates were 
calculated similarly to the incidence and prevalence rates but instead by taking the number of 
CDI associated deaths and dividing by the state population and reporting per 100,000. The yearly 
rates were then compared to the national rates as well as between each year to show trend 
direction.  
 Since C. diff has a more profound affect on the older population, an age-
adjusted mortality rate was calculated among three different age categories: 0-5, 6-64, and 65+. 
People between the ages 0 and 5 make up 6.7% of Nebraska’s population, 6 to 64 make up 
77.2%, and 65+ make up 16.1% of Nebraska’s population according to census bureau data. 
These percentages were used to calculate the denominator in our age-adjusted mortality rates for 
each year and the three-year study span. Additionally, case-fatality rates were also calculated 
yearly and over the three-year span by dividing the number of CDI deaths by the number of 
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positive cases and recorded as a percentage. Key simple descriptive information that was 
analyzed through SAS included basic counts, means, and percentage make-up of gender, race, 
ethnicity, age, sample type, test performed, infection type, and MMWR week.  
 To study vulnerabilities and CDI incidence, Nebraska counties were given a 
SVI score based on the CDC SVI scale and placed into categories of three different 
vulnerabilities: low (≤ 0.33), moderate (0.34-0.67), and high (≥ 0.68). Once gathered and 
grouped accordingly, the overall number of CDI labs, both positive and negative, of the three 
SVI categories were then compared using ANOVA testing and logistic regression in SAS.  
 Cases, deaths, mortality, incidence, and prevalence rates where then broken 
down further by local health department (LHD). Each case number for each health department is 
the culmination of all the cases recorded from each county that the local health department has 
jurisdiction over. All rates were calculated the same as the state rates except the population of 
each health departments jurisdiction was used as the denominator instead of the state population. 
All local health department populations were found by calculating the sum of each county they 
cover according to census information. 
GIS Mapping 
 2020 CDI data was used as the baseline data for the GIS map. A geographical 
map of Nebraska separated by LHD borders served as the template with which interactive 
information was entered. From there, case numbers were added up by each county within the 
same LHD and displayed within each local health department’s unique window when clicked on. 
Each health department jurisdiction was shaded based on case numbers. In addition, each health 
department’s unique incidence and mortality rates were placed along with case counts within 
their jurisdiction’s window that could be viewed when the user clicks on the jurisdiction of their 
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choice. Sections displaying the descriptive epidemiology of positive CDIs were placed next to 
the GIS map as well as the overall 2020 CDI situation to give viewers more insight. Lastly, the 
national rates were placed within the overall section for reference to Nebraska’s CDI situation 
when compared nationally. All descriptive epidemiology variables placed in the GIS map were 
graphed based on overall numbers and percentages using bar and pie graphs, respectively. 
Reporting Guidelines of the GIS Map 
 The GIS map and all results included were reported according to CDC, 
Health Insurance Portability and Accountability Act (HIPAA), and Nebraska Department of 
Health and Human Services (NDHHS) reporting guidelines and regulations. This included 
reporting CDIs by LHD jurisdiction rather than county, displaying case numbers with a certain 
minimum required, displaying reliable results that were gathered accurately with minimal 
missing data, and using the insignia and colors associated with NDHHS. 
Results 
 The overall number of positive CDIs identified in the three-year span was 
8,334 (95.63%) of 8,715 total CDI tests being administered. CDI counts were 3,296 in 2018, 
2,944 in 2019, and 2,094 in 2020. 4,844 (58.12%) of all cases were female and 3,480 (41.76%) 
were male (table 1). 10 (0.12%) case were unknown for gender. Caucasian race made up 56.10% 
(4,675) of cases, 39.56% (3,297) were unknown, 3.06% (255) African American, 0.55% (46) 
other, 0.41% (34) American Indian, 0.30% (25) Asian, and 0.02% (2) Native Hawaiian. Non-
Hispanic ethnicity made up 56.82% (4,735) of CDIs, 41.10% (3,425) unknown, and 2.09% (174) 
were of Hispanic ethnicity (table 1). PCR/NAAT tests made up 65.14% (5,429) of CDI tests, 
enzyme immunoassay toxin tests made up 32.45% (2,704) of tests. Antigen tests accounted for 
2.15% (179) of tests and culture tests made up 0.24% (20) of tests (table 1). Of positive CDIs, 
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stool samples were 98.72% (8,227), unknown samples 0.95% (79), body structure and microbial 
isolate samples 0.10% (8), urine samples 0.08% (7), blood samples 0.04% (3), and peritoneal 
fluid and abscess samples were 0.01% (1) of all collected specimens (table 1). Of all positive 
CDIs, 75.89% (6,325) were considered community-acquired infections, 14.91% (1,243) were 
considered hospital-acquired infections, and 9.19% (766) were unknown (table 1). 
 CDIs were also broken down by age groups (table 1). The median age of all 
CDIs was 65 years old (Range: 0-104 years) with the most common age (mode) being 71 years 
old (table 5). Of 8,334 CDIs, cases aged between 65-74 accounted for most cases at 21.53% 
(1,794). Cases aged between 75-84 were 17.06% (1,422), 16.02% (1,335) were between 55-64, 
people 85+ accounted for 11.77% (981), 45-54 were 8.84% (737), 0-19 were 8.72% (727), 20-34 
were 7.74% (645), and 35-44 were 7.49% (624). Unknown ages accounted for 0.83% (69) of all 
positive CDIs. Age-adjusted case-fatality rates were calculated for three different age groups as 
well (table 6). The CFR for age group 65+ was 36.95 per 100,000, 1.36 per 100,000 for ages 6-
64, and 0.00 for ages 0-5. 
  The overall number of CDI-associated deaths were 127. 2018 recorded the 
highest number of CDI associated deaths with 53 followed by 2020 with 45 and 2019 with 29 
deaths. The overall prevalence between 2018 and 2020 was calculated at 459.07 per 100,000 
people. Incidence rates for 2018, 2019, and 2020 were 205.28, 183.36, and 130.42 with mortality 
rates of 3.30, 1.81, and 2.80 per 100,000, respectively. Overall mortality rate was calculated at 
7.11 per 100,000 with an overall case-fatality rate (CFR) of 1.55%. The CFR was calculated at 
1.61% in 2018, 0.99% in 2019, and 2.15% in 2020.  
 CDIs were then broken down by LHD jurisdiction (tables 2-5). Median case 
count for CDIs in LHDs was 84 (Range: 6 – 820) in 2018, 87 (14 – 675) in 2019, and 72 (7 – 
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491) in 2020. Median incidence rates were 178.52 per 100,000 (28.56 – 308.36) in 2018, 168.67 
per 100,000 (14.28 – 427.37) in 2019, and 112.52 per 100,000 (33.32 – 321.88) in 2020. Median 
mortality rates were calculated at 2.71 per 100,000 (0.00 – 8.65) in 2018, 0.68 per 100,000 (0.00 
– 7.25) in 2019, and 2.21 per 100,000 (0.00 – 9.90) in 2020. Median CFR were 1.52% (0.00% - 
10.53%) in 2018, 0.42% (0.00% - 7.14%) in 2019, and 1.58% (0.00% - 14.29%) in 2020.  
 CDI statistics by LHD describe Nebraska’s CDI situation regionally. The 
number of LHDs with incidence rates over 100 has decreased yearly since 2018. However, six 
LHDs have seen increased incidence rates since 2018 with the highest increase occurring at 
Public Health Solutions health department with a 31.7% increase. Central District health 
department saw the highest decrease in rate at 76.9% and five total LHDs saw their rates 
decrease by half since 2018. Three LHDs saw a rise in incidence rates from 2018-2019 that were 
followed by a decrease in rates in 2020. Three LHDs saw the opposite with decreasing rates from 
2018-2019 followed by an increase in 2020. Over the course of entire study, Panhandle health 
department jurisdiction observed the highest prevalence at 699.07 while Dakota health 
department had the lowest prevalence at 76.17. 
 The ANOVA analysis calculated a p-value less than 0.001 indicating a 
difference among one or more of the SVI groups (table 7). From there, the logistic regression 
model indicated that persons in high risk SVI counties were less likely to have a CDI case than 
persons in low risk SVI counties (p<.0001), persons in high SVI counties were also less likely to 
have a CDI than persons in moderate risk SVI counties (p<.0001), and persons in low risk SVI 
counties were less likely to have a CDI than persons in moderate risk SVI counties (p=0.0437). 
Specifically, the odds that persons in moderate risk SVI counties have a CDI is 8.3 [5.4,12.8] 
times higher than high risk SVI county residents. The odds that persons in low risk SVI counties 
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have a CDI are 5.4 [4.3,6.7] times higher than moderate risk SVI county residents. The odds that 
persons in moderate risk SVI counties have a CDI are 1.5 [1.0,2.4] times higher than low risk 
SVI county residents (table 8). 
 The GIS map was created using 2020 CDI data and with an ultra-link. The 
link was placed inside the healthcare-associated infection (HAI) Data and Reports section inside 
the NDHHS HAI website displayed as “Clostridioides Difficile Cases in Nebraska 2020”. Upon 
clicking the link, users are brought to a map of Nebraska shaded different colors. The map of 
Nebraska is outlined by local health department jurisdictions with county borders inside the 
jurisdictional borders (figure 1). LHD jurisdictions are shaded according to the total CDI counts 
within their borders; light yellow implies lower case counts and darker blue implies higher case 
counts. Each LHD section can be clicked on to view their specific case number, incidence rate, 
mortality rate, and case-fatality rate (figure 2). It is important to note that the numbers are LHD 
numbers and not county numbers. In the top left corner of the map, several tabs were created to 
display certain aspects of the 2020 CDI data. The overall tab depicts the total positive CDI labs, 
the total negative CDI labs, total people tested, total deaths, state and national incidence and 
mortality rates, and the age-adjusted mortality rate for Nebraska (figure 3). In order, the other 
demographic data displayed within separate tabs were positive CDIs in 2020 by age, gender, test 
type, specimen type, infection type and CDIs by MMWR week (figures 4-9). Each demographic 
was shown as a percentage with a pie graph and overall number with a bar graph.  
Discussion 
 Overall case counts decreased yearly between 2018 and 2020; 36.5% overall 
from 2018 to 2020. The Nebraska medicine and NDHHS antimicrobial stewardship assessment 
and promotion (ASAP) coalition started in 2017 as a pilot and in 2018 engaged many facilities 
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across the state in coaching them to develop their own stewardship programs. Since 2018 
antimicrobial stewardship statewide summits have been held yearly and the focus shifted to 
reducing CDIs in Nebraska in 2019. The focus has been on messaging and education on 
promoting appropriate antibiotic use in various health care settings. The overall decline in CDI 
incidence is indicative of the positive effect infection control and prevention (ICAP) programs 
have had. The national CDI incidence rate per the CDC is 130.1 per 100,000. Although, the CDI 
incidence rates were above the national average, the incidence rate in 2020 was equal to the 
national average further highlighting the positive effects of ICAP programs. The varying 
increase and decrease in mortality rates are more difficult to explain and are as unique as the 
persons who developed complications to CDIs. However, when looking at the age-adjusted 
mortality rates it does not come as a surprise that the senior population develops complications to 
CDIs more so than the younger populations. Nevertheless, Nebraska’s CDI mortality rate of 2.8 
was also lower than the national average of 3.9 even though it rose from the preceding year.  
 The age demographics and the MMWR numbers indicate that there is no 
seasonal preference, but that CDI appears more prominent in the elderly population. This is not 
surprising to see but more so only confirms studies and reports indicating higher CDI prevalence 
in the older population. Furthermore, CDIs typically occur due to prescription overuse. Do to 
that fact and that older populations are commonly on daily medications it is not surprising to see 
the numbers higher in the older populations. Likewise, females tend to have longer lifespans than 
males. This indicates that the elderly population would have a more female prominence and 
makes sense when considering that the female gender made up 58.12% of the positive CDI 
cases. For future studies, it may be worthwhile to further breakdown the age groups to find 
possible risk factors and exposures for their CDI outcomes. Lastly, Nebraska is predominately 
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Caucasian, so it does not come as a surprise to see more than half of positive CDIs affecting this 
specific population the most as well as those of non-Hispanic ethnicity. However, the unknown 
percentage is relatively high and highlights a sizable void in lab reporting. In the future, even if 
these high unknown issues are due to patients not reporting, it is important to reach out to 
reporting facilities to discuss the importance of clear and concise reporting to understand CDIs 
within certain racial and ethnic populations. 
 C. diff typically affects the colon. Since a CDI typically constitutes as an 
infection of the colon it would be assumed a sample from the colon area would be the typical 
sample to detect C. diff. Therefore, a stool sample would be the logical choice to run a CDI lab 
test on. Our results indicate that to truly be the case with almost all positive tests using a stool 
sample. Our results have also surprisingly shown that other structures, although uncommon, can 
also be used for C. diff detection. This creates a possible case study situation for all positive CDI 
labs that did not use a stool specimen to understand symptoms exhibited by the patient and the 
potential reasonings the provider opted for a sample other than a stool sample. 
 In the world of modern medicine, it is preferable to be able to diagnose and 
treat the patient as fast as possible before complications develop. While culture tests for C. diff 
detection are the gold standard, they are usually labor intensive, require very careful quality 
control, often associated with false-positive results, and results usually take the longest to 
achieve. These reasons are usually why providers would opt for an EIA toxin, PCR/NAAT, or 
antigen test. However, while antigen tests are the most rapid test, they are not confirmatory tests 
and usually need to be combined with either a toxin or PCR/NAAT test. The results confirm that 
providers would prefer PCR/NAAT or toxin test over an antigen or culture test due to their cons. 
Both PCR/NAAT and toxin tests are rapid results, however, toxin tests are typically a cheaper 
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testing approach as opposed to PCR/NAAT testing but they are not as specific. Therefore, 
deciding on which test to perform between toxin and PCR/NAAT would appear to come down to 
provider preference. With PCR/NAAT tests accounting for 65.14% of total positive CDI tests, it 
becomes clearer that providers would prefer to have a test with high specificity and sensitivity 
performed at a higher cost. 
 Hospital acquired CDIs account for around 24 percent of all CDI infections.7 
Our results may indicate that to be the case for Nebraska as well, but they also indicate that 
hospital acquired CDIs may be less than 24 percent of all CDI case in Nebraska. Considering 
that C. diff is commonly viewed as a hospital acquired pathogen, it is preferable that future 
reporting requires strict adherence to report how the CDI was acquired.   
 Grouping counties by SVI and comparing their cumulative case numbers was 
performed as an attempt to begin understanding potential exposures that could be correlated with 
getting a CDI. The ANOVA test revealed that at least one of the SVI groups has a significantly 
higher or lower CDI caseload. However, it does not reveal which one of these groups is 
significantly different. The logistic regression analysis was performed to determine which group 
or if all the groups were different than each other, and it provided interesting results. High SVI 
counties accounted for 72.7% of all positive CDI cases during the three-year span, yet the odds 
of getting a CDI were lower than both moderate and low risk SVI counties. Considering that all 
the big metropolitan areas are in high SVI counties and therefore high SVI counties have a 
considerably higher population and thus lower incidence rates of CDIs could explain why the 
odds of getting a CDI are lower. However, that does not provide adequate explanation. Upon 
examination of the model fit statistics, the AIC, SC, and -2 Log L were all above 3,000 
suggesting that the model is not a very good fit at determining CDI outcomes. This suggestion 
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also indicates the possibility that certain social determinants and barriers within the index may 
not be adequate variables to help predict the possibility of a CDI outcome. Furthermore, SVI is 
an overgeneralization of a county and not truly indicative of the people who reside within its 
borders. To be able to understand CDI risks and exposures it is suggested to use other 
determinants or geocoding factors such as zip codes or even proximity to a medical hospital to 
discover any that may exist. 
 Creation of the GIS map required clean, accurate data with relatively low 
unknown percentages. Without complete material organized properly, GIS mapping of CDIs 
would not be considered. Furthermore, organizing the material that would be included within the 
map needed to include both valuable knowledge that could provide insight into the CDI situation 
in Nebraska and not give out any information that could lead to identification of any person who 
had either acquired a CDI or died from a CDI. The technology needed to create a GIS map is 
through the office of the chief information officer (OCIO) at the state department. Thorough 
communication is needed to establish and create the guidelines and parameters necessary to 
convey the message the map is trying to send to anyone who views it.  
 At the state and federal level, only COVID has been deemed an exception to 
all the GIS reporting guidelines. Using LHD borders and displaying rates and counts by LHD is 
one such guideline implemented by the state. This guideline was made with regards to HIPPA. 
Counties are small enough in population in Nebraska and CDIs can occur at a small enough rate 
that can make an individual identifiable. For instance, if a county had just one single CDI during 
the entire year it would make identifying that individual easier. Reporting by LHD alleviates that 
potential issue because all cases and rates are reported as a summation of all the counties that lie 
in their jurisdictions. But this does not completely get rid of the issue. Some LHDs like Douglas, 
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Lincoln/Lancaster, and Dakota LHD govern only one county and even some of the more rural 
LHD jurisdictions are capable of reporting low CDI numbers. Even though the populations 
within Douglas and Lincoln/Lancaster LHD are large enough to make identification of those 
who obtain a CDI more difficult, a minimum required number of five is required to report the 
specific number of cases and deaths. Anything less than five requires censorship per state 
guidelines. 
 Reporting numbers as a rate makes identification more difficult and also 
standardizes the burden of CDIs when trying to compare LHDs or geographical locations to 
another. Reporting incidence and mortality rates as well as overall counts by LHD in addition to 
scaling their case numbers by color paints a good story to help users visualize what the burden of 
CDIs are in each specific area. Also, as stated above, creation of the GIS map requires clean, 
accurate data, with a low percentage of unknowns. The two categories of data that did not meet 
this requirement were the ethnicity and race categories. Until these variables can reach a lower 
unknown percentage, they will remain off the GIS map. In addition, even though over 600 
facilities have been identified they must be left off the GIS dashboard as well as of now. Like 
low case numbers by county, some facilities report low numbers as well. Also, even though the 
SAS coding has three years’ worth of reporting to be able to categorize and extract the ordering 
facility, the coding still needs more refining and confirmation of accuracy by further developing 
the code over the next several years. This will help to ensure accuracy and increase confidence to 
share facility specific data. With all this in mind however, there are plans to develop an internal 
dashboard to be used by the state only. This dashboard can contain any amount of information 
desired including facility, race, and ethnicity. This provides the means of auditing the map for 
ways to improve what the external map already created can become. 
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 Putting a map into production does not happen until the map has shown the 
ability to function as a test website first. Once the map was created and shown to function 
correctly as a test website, creating a link, and placing it within the NDHHS website to access 
the map needed coordination with the state web team. The website team makes sure that the map 
is created according to the state’s reporting guidelines in addition to the correct state colors and 
ensuring the state department’s logo was displayed correctly. Deciding where the link was placed 
was up to the healthcare-associated infections epidemiology team. Once all these parameters 
were met, the map went into full production and was then able to be viewed by anyone who 
found it on the NDHHS website. 
 The map is designed to tell several different stories. The first story is the 
overall burden of CDIs on the state of Nebraska and how it compares nationally. There are very 
few states that do external reporting on their CDI burdens and even then, the other state 
departments that do report are the ones involved in the CDC’s EIP program and only report the 
numbers of their metropolitan city involved. For future purposes, it is the hope that there will be 
more accessible reports like Nebraska’s that can be incorporated into the map to compare where 
Nebraska stands on the CDI scale. The next stories are about who have been affected by CDIs 
and how CDIs have been determined. These stories are intended to enhance and promote further 
understanding of CDIs. 
 The final stories, and most important stories, are the unique CDI situations of 
each LHD embedded within the map of the state. Any persons interested in C. diff can click on 
the map and discover that the Panhandle Health Department jurisdiction has the highest CDI rate 
in Nebraska and Dakota Health Department has the lowest rate. They could also see that Loup 
Basin Health Department has the highest mortality rate and a few LHDs do not have any 
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recorded deaths. LHD information was integral in the map creation as this allows the LHDs, and 
medical personnel that reside within them, the ability to determine their specific CDI situation. 
This in return could drive change by allowing LHDs to do their own investigating and decrease 
their specific rates. Eventual integration of facilities will further boost efforts in decreasing the 
CDI burden. 
Conclusion 
 Clostridioides difficile is a mandatory reportable disease in the state of 
Nebraska, however epidemiological knowledge regarding CDI burden has been limited. This has 
left facilities and infection control and prevention teams with little understanding about current 
conditions and suppressed any progress that has been spent towards alleviating CDI conditions. 
This also obstructed in any attempts by antibiotic stewardship programs to identify where, why, 
and how interventions can be applied to any facility, clinic, or physician to eliminate needless 
prescription ordering. To better understand and create a sense of direction in targeting areas 
affected by C. diff, descriptive epidemiology and epidemiological mapping were necessary to 
understand the C. diff situation in Nebraska.  
 This project created a baseline understanding on the current and previous 
conditions of Clostridioides difficile in Nebraska. As a result of this study, we can identify over 
600 medical facilities and nursing homes across the state as well as cases by LHD that can 
continually be used to update the C. diff situation into a GIS story map. Through GIS mapping 
conceptualizing the areas hit most by C. diff are more readily available to ICAP teams thus 
decreasing the time to outbreak response. The GIS mapping is also a means for each LHD to 
view the current C. diff areas in their areas as well as the burden C. diff has on their areas. In 
addition, calculations in trends of incidence have visually demonstrated the successful attempts 
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at mitigating the CDI issue in the state showing a continued decrease in over the last three years. 
While there have been studies on the epidemiology of C. diff on a statewide scale, those studies 
did not take it further to include GIS mapping to visualize current C. diff burden in the state. 
While this is a good reactive approach to disease studying, our study takes it further to provide a 
more proactive approach in disease monitoring and prevention as the map can be updated 
regularly. This approach is key to improvement of public health effectiveness in the communities 
it serves. 
 There are a few limitations to the study. The first limitation regards data 
quality, collection, and reporting. Facility reporting is not explicit and requires detailed coding to 
dig up the true facility where the CDI occurred. Having reporting that is clear and concise allows 
for better data quality and thus more accurate data. While the SAS coding was specifically 
tailored to 2018, 2019, and 2020 data to ensure accuracy for these years specifically, the coding 
will need to continually be monitored for following years to ensure data quality is accurate. 
Furthermore, this study highlighted the limitations in understanding race and ethnicities effect on 
CDIs. This is another example ushering the need for better reporting quality into the ELR 
system. There are limitations regarding SVI and its potential correlation with CDIs. SVI is a 
generalization of each county and not specifically indicative of different communities within the 
area. Finding and using a more specific means such as zip code could provide for a better method 
to study CDIs on the population. In addition, this would create a better fitting model to 
understand and better determine vulnerabilities and their correlation with CDIs.  
 In addition, the possible effect and interaction between COVID and C. diff is 
a potential limitation to this study. While it is known that both affect older aged people and have 
diarrhea as a symptom, it is not known if COVID testing has led to decreases, or even increases, 
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in C. diff testing and detection. CDI numbers are lower in 2020, but correlation between COVID 
and C. diff is a further topic for discussion. However, moving forward from 2020, the GIS map 
created during this study will continue to serve as a point of reference for facilities and ICAP 
teams in the struggle with C. diff. 
 The overall focus on CDIs and hospital-acquired infections has increased 
dramatically within the last several years. With the map produced in this study, the CDI 
containment movement can now move with more precise actions targeted in specific areas hit by 
C. diff to mitigate both its spread and burden on the state of Nebraska. In addition, this study has 
opened the door for GIS mapping’s ability to support the public health movement of more 
innovative disease tracking of hospital-acquired infections leading to more comprehensive ways 















1 AF Shorr, MD Zilberberg, L Wang, O Baser, H Yu Mortality and costs in Clostridium 
difficile infection among the elderly in the United States Infect Control Hosp 
Epidemiol, 37 (2016), pp. 1331-1336 
2 Zhang, S., Palazuelos-Munoz, S., Balsells, E.M. et al. Cost of hospital management 
of Clostridium difficile infection in United States—a meta-analysis and modelling 
study. BMC Infect Dis 16, 447 (2016). https://doi.org/10.1186/s12879-016-1786-6 
3Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., … 
Wilcox M. H. (2010). Clinical practice guidelines for Clostridium difficile infection in 
adults: 2010 update by the society for Healthcare Epidemiology of America (SHEA) and 
the Infectious Diseases Society of America (IDSA). Infection Control and Hospital 
Epidemiology, 31, 431-455. https://doi.org/10.1086/651706  
4McHaney-Lindstrom, M., Herbert, C., Flaherty, J., Mangino, J. E., Moffatt-Bruce, S., & Root, 
E. D. (2019). Analysis of intra-hospital transfers and hospital-onset Clostridium difficile 
infection. Journal of Hospital Infection. 102(2), 168-169. 
5Yokoe, D. S., Anderson, D. J., Berenholtz, S. M., Calfee, D. P., Dubberke, E. R., Ellingson, E. 
D., … Maragakis, L. L. (2014). A compendium of strategies to prevent healthcare-
associated infections in acute care hospitals: 2014 Updates. American Journal of 
Infection Control, 42, 820-828. https://doi.org/10.1016/j.ajic.2014.07.002  
6McHaney‐Lindstrom, M., Hebert, C., Miller, H., Moffatt‐Bruce, S., & Root, E. (2020). Network 
analysis of intra‐hospital transfers and hospital‐onset clostridium difficile 
infection. Health Information and Libraries Journal, 37(1), 26-34. 
7Centers for Disease Control and Prevention. Clostridium difficile infection information for 
patients. Available from: https://www.cdc.gov/hai/organisms/cdiff/cdiff-patient.html.  
8Vatsala R., Srinivasa, Rahman Hariri, Linda R. Frank, Lawrence Kingsley, Emily Magee, 
Marian Pokrywka, Mohamed H. Yassin, Hospital-associated clostridium difficile 
infection and reservoirs within the hospital environment, American Journal of Infection 
Control, 47(2), 780-785. 
9Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room assignment and 
acquisition of Clostridium difficile infection. Infection control and hospital 
epidemiology. 2011;32(3):201-206. Doi: 10.1086/658669 
10Cai J, Zhao C, Du Y, Zhang Y, Zhao M, Zhao Q, et al. Comparative efficacy and tolerabilityof 
probiotics for antibiotic-associated diarrhea: systematic review with network meta-
analysis. United European Gastroenterol J. 2018;6(2):169–80. 
11Schäffler H, Breitrück A. Clostridium difficile-from colonization to infection. Front Microbiol. 
2018;9:646.12Dai, W., Yang, T., Yan, L. et al. Characteristics of Clostridium 
difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a 
tertiary teaching hospital in Chongqing, Southwest China. BMC Infect Dis 20, 277 
(2020). https://doi.org/10.1186/s12879-020-05014-6 
13Troppy TS, Mishra T, Barton K, et al. Using public health surveillance data to measure 
Clostridium difficile infection population burden in Massachusetts. American journal of 
infection control. 2019; 47(2):211-212. Doi:10.1016/j.ajic 2018.08.009 
14Rakibul Ahasan, Md Mahbub Hossain, Leveraging GIS and spatial analysis for informed 




15E Dong, H Du, L Gardner An interactive web-based dashboard to track COVID-19 in real time 
Lancet Infect Dis, 20 (5) (2020), pp. 533-534, 10.1016/S1473-3099(20)30120-1 
16Smith, A. B., Soto Ocana, J., & Zackular, J. P. (2020). From Nursery to Nursing Home: 
Emerging Concepts in Clostridioides difficile Pathogenesis. Infection and immunity, 
88(7), e00934-19. https://doi.org/10.1128/IAI.00934-19 
17Belmares J, Johnson S, Parada JP, Olson MM, Clabots CR, Bettin KM, Peterson LR, Gerding 
DN. 2009. Molecular epidemiology of Clostridium difficile over the course of 10 years in 
a tertiary care hospital. Clin Infect Dis 49:1141–1147. doi:10.1086/605638. 
18Campbell RR, Beere D, Wilcock GK, Brown EM. 1988. Clostridium difficile in acute and 
long-stay elderly patients. Age Ageing 17:333–336. doi:10.1093/ageing/17.5.333. 
19Bender BS, Bennett R, Laughon BE, Greenough WB, Gaydos C, Sears SD, Forman MS, 
Bartlett JG. 1986. Is Clostridium difficile endemic in chronic-care facilities? Lancet 
2:11–13. doi:10.1016/s0140-6736(86)92559-6. 
20Furuya-Kanamori L, Clements ACA, Foster NF, Huber CA, Hong S, Harris-Brown T, Yakob 
L, Paterson DL, Riley TV. 2017. Asymptomatic Clostridium difficile colonization in two 
Australian tertiary hospitals, 2012–2014: prospective, repeated cross-sectional study. Clin 
Microbiol Infect 23:48.e1–48.e7. doi:10.1016/j.cmi.2016.08.030. 
21Nguyen, H.Q., Tunney, M.M. & Hughes, C.M. Interventions to Improve Antimicrobial 
Stewardship for Older People in Care Homes: A Systematic Review. Drugs Aging 36, 
355–369 (2019). https://doi.org/10.1007/s40266-019-00637-0 
22Stuart RL, Wilson J, Bellaard-Smith E, et al. Antibiotic use and misuse in residential aged care 
facilities. Intern Med J. 2012;42(10):1145–9. 
23McClean P, Tunney M, Gilpin D, Parsons C, Hughes C. Antimicrobial prescribing in 
residential homes. J Antimicrob Chemother. 2012;67(7):1781–90. 
24Van Buul LW, Van der Steen JT, Veenhuizen RB, et al. Antibiotic use and resistance in long 
term care facilities. J Am Med Direct Assoc. 2012;13(6):568.e1–13. 
25Van Buul LW, Veenhuizen RB, Achterberg WP, et al. Antibiotic prescribing in Dutch nursing 
homes: how appropriate is it? J Am Med Direct Assoc. 2015;16(3):229–37. 
26Lim CJ, Kong DC, Stuart RL. Reducing inappropriate antibiotic prescribing in the residential 
care setting: current perspectives. Clin Interv Aging. 2014;9:165–77. 
27Peron EP, Hirsch AA, Jury LA, Jump RL, Donskey CJ. Another setting for stewardship: high 
rate of unnecessary antimicrobial use in a veterans affairs long-term care facility. J Am 
Geriatr Soc. 2013;61(2):289–90. 
28Morgan, F., Belal, M., Lisa, B., Ford, F., LeMaitre, B., & Psevdos, G. (2020). Antimicrobial 
stewardship program achieved marked decrease in Clostridium difficile infections in a 
Veterans Hospital. American Journal of Infection Control, 48(9), 1119–1121. 
https://doi.org/10.1016/j.ajic.2019.12.023 
29Sara Stream, MD, David Alfandre, MD, MSPH, “Just Getting a Cup of Coffee”—Considering 
Best Practices for Patients’ Movement off the Hospital Floor. J. Hosp. Med 2019;11;712-












Table 2. CDIs by year with LHDs. 










Table 4. CDI mortality rates by year with LHDs. 















Table 6. Age-adjusted CFR. Population percentage based on 2010 census data. 
Table 7. ANOVA analysis on SVI groups per case number. 













Figure 1. GIS map of 2020 CDI data. 












Figure 3. GIS map of 2020 CDI data displaying LHD data. 











Figure 5. GIS map of 2020 CDI data displaying test type demographics. 











Figure 7. GIS map of 2020 CDI data displaying infection type demographics. 
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Academic Projects and Achievements 
APEX, Department of Neurological Sciences – Multiple Sclerosis (MS) Clinic, University of 
Nebraska Medical Center 
May 2020 to August 2020 
 
     Specific duties and accomplishments 
o Attended clinical sessions with MS providers. Sessions included house 
calls, transdisciplinary clinic and community partnership program, and 
telemedicine visits 
o Identified and created data repository to arrive at estimates of the 
number of individuals with MS and significant disabilities 
o Contributed to the strategic planning of identifying stakeholders who are 
interested in the field of disability/disparities/social determinates, and 
health care 
o Assisted in creating awareness in the community for individuals with 
MS 
o Developed a policy brief that highlights keep issues faced by those with 
MS as well as solutions 
 
Capstone, Nebraska Department of Health and Human Services, Public Health Division 




     Specific duties and accomplishments 
o Defined the epidemiology of Clostridioides difficile in Nebraska 
between 2018-2020 
o Described the demographical data of all Clostridium difficile infection 
(CDI) cases in Nebraska 
o Determined the efficacy of Nebraska’s antimicrobial stewardship 
programs by assessing trend data between 2018-2020 
o Attempted to discover other potential at-risk populations outside the 
healthcare and long-term care facility realms by using the social 
vulnerability index (SVI) 
o Created a geographic information system (GIS) map designed to convey 
the most up-to-date CDI information for future monitoring. This map 
will be used as a template for all healthcare-acquired diseases (HAIs) in 
Nebraska 
o Created a SAS code used as a template to identify all (HAIs) 
o Identified over 600 medical facilities, nursing homes, rehabilitation 
centers, assisted living facilities, and skilled nursing facilities in the state 
of Nebraska 
o Created a foundational solution to enhance outbreak response and 
display real time disease information  
 
Appointments and Positions 
Heath Surveillance Specialist, Nebraska Department of Health and Human Services 
(NDHHS), Public Health Division 
June 2020 to present 
 
NDHHS Public Health is the state appoint division to assist and help all Nebraskans in 
public health matters across the state. This division is responsible for preventive and 
community health programs and services. It is also responsible for the regulation and 
licensure of health-related professions and occupations, as well as the regulation and 
licensure of health care facilities and services. 
 
     Specific duties and accomplishments 
o Contact tracing team lead and liaison between the state department, 
Douglas County Health Department (DCHD), and third-party contact 
tracing vendor Professional Research Consulting (PRC) 
o Assisted in creation and training of contract tracing techniques and SOPs 
with third-party contact vendors 
o Developed an efficient method to record COVID hospitalizations 
Epidemiological work in COVID hospitalization outcomes still ongoing 
o Assisted in establishing new contact tracing software move from 
REDcap to SalesForce 
 
Subject Matter Expert (volunteer), Pandemic Planning Leadership Team, University of Nebraska 
Medical Center 




The Pandemic Planning Leadership Team was created by UNMC to oversee several 
committees in the preparation of the impending COVID pandemic for both UNMC and 
the state of Nebraska 
  
Specific duties and accomplishments 
o Revised the UNMC Pandemic Plan tailored specifically to COVID 
o Served each committee on the team as a point of information for them to 
adequately plan for COVID pandemic 
o Created basic “best guess” epidemiology of COVID during Wuhan 
outbreak to determine future burden on the state of Nebraska 
o Calculated potential future burn rates of personal protective equipment 
(PPE) and inventory 
o Assisted in creation of personnel tracker and morgue reports 
o Developed predicted UNMC hospital resource usage and predicted 
COVID outcomes for Douglas County 
o Developed state, UNMC, and various other hospital COVID caseload and 
death predictions using gamma distribution. Depicted the role of 
mitigation or “flattening the curve” of COVID on hospital surge capacity 
and its importance in Nebraska 
o Assisted in information gathering in the creation of UNMC’s COVID 
dashboard 
o Assisted in sample collection, literature review, and data management of 
project in determining COVID in wastewater. 
o Participated in presentations demonstrating basic knowledge of COVID 
and diseases in addition to potential burdens of COVID on the community 
of Nebraska 
 
Cytogenetic Technologist, Munroe-Meyer Human Genetics Lab (HGL), University of Nebraska 
Medical Center 
July 2017 to February 2020 
 
UNMC HGL combines comprehensive genetic testing with personalized clinical 
consultation to provide the very best in genetic medicine to every client and patient 
 
       Specific duties and accomplishments 
o Perform tissue culture & DNA extraction on human samples 
o Prepare G-banded slides and hybridize DNA probes for analysis of 
genetic disorders 
o Use bright field and fluorescent microscopes with a computer imaging 
system to prepare karyotypes and digitized fluorescence in situ 
hybridized (FISH) images 
o Interpret and summarize karyotypes and FISH results and write 




o Developed procedural use of ROBOSEP for lymph node and bone 
marrow core samples 
o Developed more efficient way of freezing patient samples. Decreasing 
time to perform task exponentially 
 
Interventionalist (volunteer), Occupational/Physical Therapy Department, University of 
Nebraska Medical Center 
June 2015 to August 2015 
 
Specific duties and accomplishments 
o Communicate, participate in activities that incorporated the Hand Arm 
Bimanual Intensive Therapy (HABIT) guidelines, and monitor progress in 
children with Hemiplegic Cerebral Palsy 
o Exhibited progress in patient motor functioning in both fine and gross 
motor skills 
 
